Pirtobrutinib, Venetoclax, and Rituximab (PROVEN) in previously untreated WM

Recruiting
Written By Sustainable Digital

First trial using a non-chemo, fixed-duration, triple combination for WM in the world

Sites: Memorial Sloan Kettering Cancer Center. Pending at Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center

Accrual status: 5 of 40 patients

Sustainable Digital

Digital Communication services, including website design, search engine optimization, social media, and content creation for nonprofit organizations, consultants, and creative entrepreneurs.

http://www.sustainabledigital.com
Previous

Epcoritamab in previously treated WM
Next

Etentamig in previously treated WM